Rebalix
iShares · sheet of 10 September 2026
iShares · sheet of 10 September 2026ETF sheet · official issuer and register data
iShares $ Intermediate Credit Bond UCITS ETF GBP Hedged
ICBH · IE0002O230L3 · class Hedged · GBP · domicile Ireland
Bonds · Corporate · 1-10 years · North AmericaGBP-hedged share classSFDR art. 6
Index tracked: Bloomberg U.S. Intermediate Credit Index
- TER
- 0.18%+ trans. 0.01%
- Fund size
- 2 m EUR
- Tracking difference
- +0.00%3-year avg
- 🇮🇹 tax rate
- 24.69%white list 9.74%
- Replication
- Physical (optimised)
- Income
- Distributingquarterly
- Duration
- 4.06 yrsmedium (3–7 years)
Launch 8 May 2025 · costs from the KID as of 2 Sept 2026 · 5,932 securities held
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Share Class is a share class of a Fund which aims to achieve a return on your investment, through a combination of capital growth and income on the Fund’s assets, which reflects the return of the Bloomberg U.S. Intermediate Credit Bond Index (Total Return), ("Index"). The Fund is passively managed, and aims to invest so far as possible and practicable in the fixed income (FI) securities (such as bonds) that make up the Index and comply with its credit rating requirements. If the credit ratings of the FI securities are downgraded, the Fund may…
Performance since series start (in euro) — base 100
8 May 2025 → 31 Aug 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +3.4% |
| 3 years | series too young |
| 5 years | series too young |
| 10 years | series too young |
| Since series start | +4.0% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 3.86% | 3.86% | — |
| Max drawdown | −4.60% | −4.60% | — |
| Sharpe | -1.39 | -1.39 | — |
| Sortino | -1.60 | -1.60 | — |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · ICBH · IE0002O230L31
RebalixICBH · IE0002O230L3 · sheet of 10 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · declared by the issuer
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +0.00% | +0.00% | +0.00% |
| 2024 | +0.00% | +0.00% | +0.00% |
| 2023 | +0.00% | +0.00% | +0.00% |
| 2022 | +0.00% | +0.00% | +0.00% |
| 2021 | +0.00% | +0.00% | +0.00% |
Fixed income — as declared by the issuer
Issuer page · 20 Aug 2026 · investment-grade share (BBB−/Baa3 and above): 100.1%
Rating breakdown (% of fund)
Maturity breakdown (% of fund)
Distributions · per share, in GBP
Frequency: quarterly · last 12 months: 0.22 GBP (4.41% of NAV) · last ex-date 16 Jul 2026
| Year | Payments | Total (GBP) |
|---|---|---|
| 2026 | 3 | 0.22 |
| 2025 | 1 | 0.03 |
Holdings
Portfolio as declared by the issuer · 31 Aug 2026 · 5,932 securities · top-10 weight = 1.1%
Countries (% of fund)
Sectors (% of fund)
Listing venues
ESMA register (FIRDS) and official exchange lists
No EU listing in the ESMA register.
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/IE0002O230L3
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/IE0002O230L3
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · ICBH · IE0002O230L32